DB
Donald A Bergstrom
President, R&D

Donald A Bergstrom insider trades: Relay Therapeutics (RLAY) stock sales

President, R&D, Relay Therapeutics Last trade Oct 28, 2026 65 Form 4 filings
$2.0M
Sold, last 12 months
6 sales
$0
Bought, last 12 months
0 buys
52
Open-market trades
since 2021
3
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Donald reports to the SEC

Open-market buys and sales

52 trades reported on SEC Form 4, newest first

DateStockTypeValue
Oct 28, 2026RLAY↓ Sell$42K
Jul 28, 2026RLAY↓ Sell$42K
Jul 6, 2026RLAY↓ Sell$162K
Jun 22, 2026RLAY↓ Sell$1.6M
Apr 28, 2026RLAY↓ Sell$22K
Jan 28, 2026RLAY↓ Sell$167K
Oct 28, 2025RLAY↓ Sell$225K
Jul 29, 2025RLAY↓ Sell$113K
Apr 30, 2025RLAY↓ Sell$95K
Mar 27, 2025RLAY↓ Sell$3K
Jan 30, 2025RLAY↓ Sell$362K
Dec 27, 2024RLAY↓ Sell$3K
Oct 28, 2024RLAY↓ Sell$16K
Sep 27, 2024RLAY↓ Sell$5K
Jul 29, 2024RLAY↓ Sell$24K
Jun 27, 2024RLAY↓ Sell$4K
Apr 29, 2024RLAY↓ Sell$17K
Mar 27, 2024RLAY↓ Sell$6K
Jan 29, 2024RLAY↓ Sell$31K
Dec 27, 2023RLAY↓ Sell$11K
Oct 30, 2023RLAY↓ Sell$21K
Sep 27, 2023RLAY↓ Sell$5K
Jul 28, 2023RLAY↓ Sell$32K
Jun 27, 2023RLAY↓ Sell$8K
Apr 28, 2023RLAY↓ Sell$15K
Mar 27, 2023RLAY↓ Sell$12K
Jan 30, 2023RLAY↓ Sell$31K
Dec 27, 2022RLAY↓ Sell$14K
Nov 1, 2022RLAY↓ Sell$221K
Oct 3, 2022RLAY↓ Sell$179K
Sep 27, 2022RLAY↓ Sell$22K
Sep 8, 2022RLAY↓ Sell$750K
Sep 2, 2022RLAY↓ Sell$125K
Sep 1, 2022RLAY↓ Sell$187K
Aug 24, 2022RLAY↓ Sell$375K
Aug 5, 2022RLAY↓ Sell$160K
Jul 28, 2022RLAY↓ Sell$39K
Jul 6, 2022RLAY↓ Sell$160K
Jun 27, 2022RLAY↓ Sell$180K
May 2, 2022RLAY↓ Sell$366K
Apr 1, 2022RLAY↓ Sell$546K
Mar 29, 2022RLAY↓ Sell$19K
Mar 24, 2022RLAY↓ Sell$300K
Mar 10, 2022RLAY↓ Sell$250K
Mar 1, 2022RLAY↓ Sell$191K
Feb 22, 2022RLAY↓ Sell$482K
Dec 27, 2021RLAY↓ Sell$21K
Oct 15, 2021RLAY↓ Sell$1.0M
Sep 27, 2021RLAY↓ Sell$24K
Jun 28, 2021RLAY↓ Sell$35K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other RLAY insiders

Open-market trades in the last 12 months

About Donald A Bergstrom's insider trades

Donald A Bergstrom is President, R&D at Relay Therapeutics (RLAY). Since Apr 16, 2021, Donald has reported no open-market purchases and 52 sales worth $12.0M on SEC Form 4. In the last 12 months: 6 sales ($2.0M).

Their filings also include option exercises (17 filings), grants and awards (14 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every RLAY insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.